Nektar Therapeutics

The current price of NKTR is 1.32 USD — it has decreased by 2.22% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Nektar Therapeutics stocks are traded under the ticker NKTR.

Nektar Therapeutics is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

NKTR stock is 7.09% volatile and has beta coefficient of 0.43. Check out the list of the most volatile stocks — is Nektar Therapeutics there?

One year price forecast for Nektar Therapeutics has a max estimate of 5.00 USD and a min estimate of 1.00 USD.

NKTR earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.20 USD resulting in a −21.02% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Nektar Therapeutics earnings.

Nektar Therapeutics revenue for the last quarter amounts to ‪24.14 M‬ USD despite the estimated figure of ‪21.26 M‬ USD. In the next quarter revenue is expected to reach ‪21.43 M‬ USD.

Yes, you can track Nektar Therapeutics financials in yearly and quarterly reports right on TradingView.

NKTR net income for the last quarter is ‪−42.08 M‬ USD, while the quarter before that showed ‪−45.84 M‬ USD of net income which accounts for 8.20% change. Track more Nektar Therapeutics financial stats to get the full picture.

Today Nektar Therapeutics has the market capitalization of ‪242.38 M‬, it has increased by 37.89% over the last week.

No, NKTR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, NKTR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nektar Therapeutics stock right from TradingView charts — choose your broker and connect to your account.

NKTR reached its all-time high on Mar 12, 2018 with the price of 111.36 USD, and its all-time low was 0.41 USD and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 137.00 employees. See our rating of the largest employees — is Nektar Therapeutics on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nektar Therapeutics technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nektar Therapeutics stock shows the neutral signal. See more of Nektar Therapeutics technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Nektar Therapeutics future price: according to them, NKTR price has a max estimate of 5.00 USD and a min estimate of 1.00 USD. Read a more detailed Nektar Therapeutics forecast: see what analysts think of Nektar Therapeutics and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nektar Therapeutics EBITDA is ‪−127.41 M‬ USD, and current EBITDA margin is −143.82%. See more stats in Nektar Therapeutics financial statements.